Cargando…

Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies

Detalles Bibliográficos
Autores principales: Trentin, Francesca, Gatto, Mariele, Zen, Margherita, Larosa, Maddalena, Nalotto, Linda, Saccon, Francesca, Zanatta, Elisabetta, Iaccarino, Luca, Doria, Andrea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182622/
https://www.ncbi.nlm.nih.gov/pubmed/30140999
http://dx.doi.org/10.1007/s12016-018-8704-1
_version_ 1783362608319954944
author Trentin, Francesca
Gatto, Mariele
Zen, Margherita
Larosa, Maddalena
Nalotto, Linda
Saccon, Francesca
Zanatta, Elisabetta
Iaccarino, Luca
Doria, Andrea
author_facet Trentin, Francesca
Gatto, Mariele
Zen, Margherita
Larosa, Maddalena
Nalotto, Linda
Saccon, Francesca
Zanatta, Elisabetta
Iaccarino, Luca
Doria, Andrea
author_sort Trentin, Francesca
collection PubMed
description
format Online
Article
Text
id pubmed-6182622
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-61826222018-10-24 Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies Trentin, Francesca Gatto, Mariele Zen, Margherita Larosa, Maddalena Nalotto, Linda Saccon, Francesca Zanatta, Elisabetta Iaccarino, Luca Doria, Andrea Clin Rev Allergy Immunol Correction Springer US 2018-08-23 2018 /pmc/articles/PMC6182622/ /pubmed/30140999 http://dx.doi.org/10.1007/s12016-018-8704-1 Text en © The Author(s) 2018 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Correction
Trentin, Francesca
Gatto, Mariele
Zen, Margherita
Larosa, Maddalena
Nalotto, Linda
Saccon, Francesca
Zanatta, Elisabetta
Iaccarino, Luca
Doria, Andrea
Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
title Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
title_full Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
title_fullStr Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
title_full_unstemmed Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
title_short Correction to: Effectiveness, Tolerability, and Safety of Belimumab in Patients with Refractory SLE: a Review of Observational Clinical-Practice-Based Studies
title_sort correction to: effectiveness, tolerability, and safety of belimumab in patients with refractory sle: a review of observational clinical-practice-based studies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6182622/
https://www.ncbi.nlm.nih.gov/pubmed/30140999
http://dx.doi.org/10.1007/s12016-018-8704-1
work_keys_str_mv AT trentinfrancesca correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT gattomariele correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT zenmargherita correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT larosamaddalena correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT nalottolinda correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT sacconfrancesca correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT zanattaelisabetta correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT iaccarinoluca correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies
AT doriaandrea correctiontoeffectivenesstolerabilityandsafetyofbelimumabinpatientswithrefractorysleareviewofobservationalclinicalpracticebasedstudies